Thursday, October 29, 2020

REFERENCES

1.  Rochelle, R., C., Othávio, P., B., Pedro, F., Flávio, A., Castro (2018).  Sampling procedures and calculation for sample size determination: criteria and methods adopted in theses and dissertations in Human Movement Sciences - a descriptive study.  Retrieved online https://doi.org/10.5007/1980-0037.2018v20n5p480 [12-oct-2020]

2.  Rensburg, V., R., Reuter, H. (2019).  An overview of analgesics: NSAIDs, paracetamol, and topical analgesics Part 1:  South African Family Practice, 61:sup1, S4-S10, retrieved online <DOI: 10.1080/20786190.2019.1610228> [23-December-2019]

3.  Amol, B., D, Jayprabha, R., Dhumane, Hrushikesh, V., Wagh, Rushikesh, B., S. (2019).  Asian Journal of Pharmaceutical Research and Development:  Open Access to Pharmaceutical and Medical Research. Retrieved online <15.12.2019 at http://ajprd.com> [March-17-2020]

4.  Jaycharan, C., Tamoghna, B. (2013).  How to calculate sample size for different study designs in medical research?  Indian Journal of medical research.  Retrieved online [December-20-2016]

5.  Laura, J., Hunter, Wood, M., D., Dargan, P., I. (2011).  The patterns of toxicity and management of acute nonsteroidal anti-inflammatory drug (NSAID) overdose:  Dove press journal.  Retrieved online <http://dx.doi.org/10.2147/OAEM.S22795> [June-3-2019]

6.  Centre for disease control and prevention [CDC] (2019).  Viral Hemorrhagic Fevers.  Fact sheet.  Retrieved online [27-March-2019]

7.  Amol, B., D, Jayprabha, R., Dhumane, Hrushikesh, V., Wagh, Rushikesh, B., S. (2019).  The Stages of Drug Discovery and Development Process;  Asian Journal of Pharmaceutical Research and Development: Retrieved online <15.12.2019 at http://ajprd.com> [March-10-2019]

8.  Cotran, R., S., Kumar, V., Collins, T. (2012).  Robins pathologic basis of diseases. J.B.Saunders Company Philadilphia, 6th edition

9.  Dey, N., C., Dey, T., K. (2014).  A Textbook of Pathology Calcatta, Messers Allied agency 10th edition 2014

10.  Gashaw, I., Ellinghaus, P., Sommer, A., Asadullah, K. (2012).  What makes a good drug target.  Drug Discovery Today, 17:S24-S30.

11.  Karara, A., H., Edeki, T., McLeod, J. (2010).  PhRMA survey on the conduct of first-in-human clinical trials under exploratory investigational new drug applications.  Journal of ClinicalPharmacology, 50:380– 391.

12.  Moffat, J., Vincent, F., Lee, J., Eder, J., Prunotto, M. (2017).  Opportunities and challenges in phenotypic drug discovery: an industry perspective.  Nature Reviews Drug Discovery, 16(8):531-543

13.  Patidar, A., K., Selvam, G., Jeyakandan, M., Mobiya, A., K., Bagherwal, A., Sanadya, G., Mehta, R. (2011). Lead Discovery and lead optimization: A useful strategy in molecular modification of lead compound in analog design. International journal of drug design and discovery. 2(2):458- 463.

14.  Winge, D., R. (2012). Principles of molecular biology.  32(14): 2647–2652 Retrieved onloine <doi: 10.1128/MCB.00573-12>  [12-12-2020]


No comments:

Post a Comment

MOST FREQUENTLY READ